Jubilant Life Sciences announced on Friday that it has received approval from the US Food and Drugs Administration (FDA) to market a generic diuretic medicine. The company has received abbreviated new drug application approval to market Spironolactone tablets (25 mg, 50 mg and 100 mg). These tablets are the generic version of GD Searle's Aldactone. Spironolactone is used to treat fluid retention caused by conditions such as congestive heart failure and cirrhosis of ...
Read More
You have just read an article categorized health
titled Jubilant Gets FDA Nod for Generic Diuretic Medicine.
Written by:
editor -
Monday, April 28, 2014
There are currently no comments for "Jubilant Gets FDA Nod for Generic Diuretic Medicine"
Post a Comment